Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04468984
Title Safety, Efficacy, and Assessment of Change in Spleen Volume Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet in Adult Participants With Relapsed/Refractory Myelofibrosis (TRANSFORM-2)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

myelofibrosis

Therapies

Navitoclax + Ruxolitinib

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.